Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01548144
Recruitment Status : Terminated (PI request)
First Posted : March 8, 2012
Last Update Posted : September 13, 2021
Information provided by (Responsible Party):
M.D. Anderson Cancer Center